Omada Health, Inc. (OMDA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 30M 60M 90M Q3 '24: 45.5M Q4 '24: 48M Q1 '25: 55M Q2 '25: 61.4M Q3 '25: 68M Q4 '25: 75.8M Q1 '26: 78M Q2 '26: 87.8M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

0 25M 50M 75M Q3 '24: 28.6M Q4 '24: 32.1M Q1 '25: 31.9M Q2 '25: 40.3M Q3 '25: 45.1M Q4 '25: 53.7M Q1 '26: 48.7M Q2 '26: 63.8M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Income Quarterly

-9M -6M -3M 0 3M 6M 9M Q3 '24: -8.5M Q4 '24: -7.1M Q1 '25: -8.4M Q2 '25: -4.3M Q3 '25: -2.5M Q4 '25: 3.3M Q1 '26: -4.8M Q2 '26: 3.5M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q3 '24: -9.2M Q4 '24: -8.2M Q1 '25: -9.4M Q2 '25: -5.3M Q3 '25: -3.2M Q4 '25: 5.2M Q1 '26: -3M Q2 '26: 5.3M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

0 10M 20M 30M Q3 '24: 17M Q4 '24: 15.8M Q1 '25: 23.1M Q2 '25: 21.1M Q3 '25: 23M Q4 '25: 22.2M Q1 '26: 29.4M Q2 '26: 24M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow Quarterly

-24M -16M -8M 0 8M 16M 24M Q3 '24: 1.1M Q4 '24: -6.5M Q1 '25: -16.1M Q2 '25: 2.9M Q3 '25: 10.1M Q4 '25: 21.4M Q1 '26: -11.8M Q2 '26: 4M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

-24M -16M -8M 0 8M 16M 24M Q3 '24: 980K Q4 '24: -6.7M Q1 '25: -16.4M Q2 '25: 2.6M Q3 '25: 9.6M Q4 '25: 21.2M Q1 '26: -11.9M Q2 '26: 3.9M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 25M 50M 75M Q2 '24: 7.6M Q3 '24: 7.8M Q1 '25: 8.2M Q2 '25: 22M Q3 '25: 57.7M Q1 '26: 58.9M Q2 '26: 63.9M Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-7.50 -5.00 -2.50 0.00 2.50 5.00 7.50 Q4 '24: -6.11 Q1 '25: -4.75 Q2 '25: -3.59 Q3 '25: -2.47 Q4 '24 Q1 '25 Q2 '25 Q3 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.